Literature DB >> 1416852

Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium.

L B Heifets1, P J Lindholm-Levy, R D Comstock.   

Abstract

The inhibitory activity of gentamicin against Mycobacterium avium depended on the pH of the medium, and the broth-determined MICs for 90% of strains were 5.0 micrograms/ml at pH 7.4, 9.5 micrograms/ml at pH 6.8, and greater than 16.0 micrograms/ml at pH 5.0. The MBCs were two- to eightfold higher than the MICs. The combined effect of gentamicin and clarithromycin was additive, and the MICs and MBCs of each drug were either the same as those in the single-drug tests or reduced twofold.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1416852      PMCID: PMC192032          DOI: 10.1128/AAC.36.8.1695

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

2.  In vitro susceptibility of Mycobacterium avium complex to antibacterial agents.

Authors:  C E Davis; J L Carpenter; S Trevino; J Koch; A J Ognibene
Journal:  Diagn Microbiol Infect Dis       Date:  1987-11       Impact factor: 2.803

3.  Recent microbiological studies with gentamicin.

Authors:  J A Waitz; M J Weinstein
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

4.  Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice.

Authors:  S P Klemens; M H Cynamon; C E Swenson; R S Ginsberg
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

5.  Comparative in vitro activity of kanendomycin, kanamycin, gentamicin and streptomycin against 100 consecutive cultures of tubercle bacilli recovered from patients.

Authors:  H O Tanzil; R R Utomo
Journal:  Paediatr Indones       Date:  1974 Jan-Feb

6.  Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.

Authors:  W E Sanders; R Cacciatore; H Valdez; I Pejovic; F P Dunbar
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Tuberculostatic effect of gentamicin in vitro.

Authors:  Z Jedlicková; J Sulová
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1967

8.  Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis.

Authors:  L Heifets; P Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

9.  Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium.

Authors:  L B Heifets; P J Lindholm-Levy; R D Comstock
Journal:  Am Rev Respir Dis       Date:  1992-04

10.  In vitro anti-mycobacterial activity of some new amino-glycoside antibiotics.

Authors:  P R Gangadharam; E R Candler
Journal:  Tubercle       Date:  1977-03
View more
  6 in total

1.  Staphylococcal ClpXP protease targets the cellular antioxidant system to eliminate fitness-compromised cells in stationary phase.

Authors:  Abdulelah A Alqarzaee; Sujata S Chaudhari; Mohammad Mazharul Islam; Vikas Kumar; Matthew C Zimmerman; Rajib Saha; Kenneth W Bayles; Dorte Frees; Vinai C Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 11.205

2.  Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium.

Authors:  N Mor; J Vanderkolk; N Mezo; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

Review 3.  Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.

Authors:  L B Barradell; G L Plosker; D McTavish
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

4.  Postantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complex.

Authors:  L C Ellis; C A Benson; G I Koenig; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

5.  Treatment of refractory Crohn's disease and pyoderma gangrenosum with a combination regimen of rifaximin, gentamicin and metronidazole.

Authors:  Neil D Goldberg; Aravinda Vadlamudi; Nicole Parrish
Journal:  Case Rep Gastroenterol       Date:  2015-01-24

6.  Optimization of In Vitro Mycobacterium avium and Mycobacterium intracellulare Growth Assays for Therapeutic Development.

Authors:  Lauren Auster; Morgan Sutton; Mary Chandler Gwin; Christopher Nitkin; Tracey L Bonfield
Journal:  Microorganisms       Date:  2019-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.